Functional diversity increases the efficacy of phage combinations (2021)
Attributed to:
Does CRISPR-Cas immunity limit the effectiveness of phage therapy?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.07.09.451746
Publication URI: http://dx.doi.org/10.1101/2021.07.09.451746
Type: Preprint